Skip to main content
Matthew R. Morrell
( out of 55 reviews )

Matthew R. Morrell, MD

Languages spoken: English, Spanish

Clinical Locations

University of Utah Hospital

Salt Lake City
801-581-2121
  • Matthew R. Morrell joins the division of Pulmonary and Critical Care as a Professor of Medicine.


    He obtained a bachelor of science in chemistry at the University of Utah, where he graduated summa cum laude. He attended the David Geffen School of Medicine at the University of California Los Angeles where he was elected to the Alpha Omega Alpha Medical Honor Society after his second year and ultimately graduated with honors. Dr. Morrell completed his internal medicine residency and his fellowship in pulmonary and critical care at Washington University in St. Louis/Barnes-Jewish Hospital. He was recruited to the University of Pittsburgh in the division of pulmonary, allergy and critical care medicine as an assistant professor and a lung transplant pulmonologist. Dr. Morrell served as the director of the pulmonary stepdown unit at the University of Pittsburgh Medical Center. In 2016, he was appointed as the medical director of the lung transplant program and promoted to the academic rank of associate professor. His passion for expanding access to lung transplantation through organ donation led him to be appointed the medical director of the Center for Organ Recovery and Education (CORE), the region’s local organ procurement organization.


    Dr. Morrell has been involved in medical education of medical students, residents and fellows and has served as the pulmonary transplant fellowship director at the University of Pittsburgh. He is an active member of the International Society of Heart and Lung Transplantation and the American Thoracic Society. Dr. Morrell is excited to join the faculty at the University of Utah and the lung transplant program as the medical director. He hopes to promote organ donation and provide increased opportunities for lung transplantation to the people here in the mountain west. In his spare time, Dr. Morrell enjoys attending his children’s football games and swim meets. He is an avid cross country runner and pipe organ player.

    Board Certification

    American Board of Internal Medicine (Sub: Critical Care Medicine)
    American Board of Internal Medicine (Sub: Pulmonary Disease)

    Patient Rating

    4.9 /5
    ( out of 55 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety.
    Patients are de-identified for confidentiality and patient privacy.

    August 25, 2023
    UH HOSPITALS AND CLINICS

    Dr. Morrell was very good at his job. I just have a problem being told that I will do as he says or he will not care for me. I understand with a transplant that is what has to happen but I still want to have a say in my care.

    August 24, 2023
    UH HOSPITALS AND CLINICS

    He is very knowledgeable about the procedure and in explaining the next steps.

    August 12, 2023
    UH HOSPITALS AND CLINICS

    He cares about his patients

    July 20, 2023
    UH HOSPITALS AND CLINICS

    He made me feel that I was worth the effort we were going through.

    July 13, 2023
    UH HOSPITALS AND CLINICS

    A awesome doctor rated a 10

    July 12, 2023
    UH HOSPITALS AND CLINICS

    Dr. Morrell is a very knowledgeable man. He reviews my test results and chart before my visit so that we can address any issues of concern. I like how he explains things to me and that he listens to what I have to say. He has a wonderful bedside manner and is always professional. He makes me feel like I am a very important patient and treats me with respect. I am able to ask him questions and he always has an answer for me. I am very blessed that he is part of the Lung Transplant Team and has a part in my care.

    July 07, 2023
    UH HOSPITALS AND CLINICS

    A very good doctor.

    May 26, 2023
    UH HOSPITALS AND CLINICS

    Although very competent and professional he makes one feel comfortable and at easy. Definitely in good hands.

    May 24, 2023
    UH HOSPITALS AND CLINICS

    Great guy, good communicater, cared about us and did not try to sell us. He agreed that it was a tough decision for me.

  • Matthew R. Morrell joins the division of Pulmonary and Critical Care as a Professor of Medicine.


    He obtained a bachelor of science in chemistry at the University of Utah, where he graduated summa cum laude. He attended the David Geffen School of Medicine at the University of California Los Angeles where he was elected to the Alpha Omega Alpha Medical Honor Society after his second year and ultimately graduated with honors. Dr. Morrell completed his internal medicine residency and his fellowship in pulmonary and critical care at Washington University in St. Louis/Barnes-Jewish Hospital. He was recruited to the University of Pittsburgh in the division of pulmonary, allergy and critical care medicine as an assistant professor and a lung transplant pulmonologist. Dr. Morrell served as the director of the pulmonary stepdown unit at the University of Pittsburgh Medical Center. In 2016, he was appointed as the medical director of the lung transplant program and promoted to the academic rank of associate professor. His passion for expanding access to lung transplantation through organ donation led him to be appointed the medical director of the Center for Organ Recovery and Education (CORE), the region’s local organ procurement organization.


    Dr. Morrell has been involved in medical education of medical students, residents and fellows and has served as the pulmonary transplant fellowship director at the University of Pittsburgh. He is an active member of the International Society of Heart and Lung Transplantation and the American Thoracic Society. Dr. Morrell is excited to join the faculty at the University of Utah and the lung transplant program as the medical director. He hopes to promote organ donation and provide increased opportunities for lung transplantation to the people here in the mountain west. In his spare time, Dr. Morrell enjoys attending his children’s football games and swim meets. He is an avid cross country runner and pipe organ player.

    Board Certification and Academic Information

    Academic Departments Internal Medicine -Primary
    Academic Divisions Public Health
    Board Certification
    American Board of Internal Medicine (Sub: Critical Care Medicine)
    American Board of Internal Medicine (Sub: Pulmonary Disease)

    Education history

    Fellowship Pulmonary & Critical Care - Washington University/Barnes-Jewish Hospital Fellow
    Internal Medicine - Washington University/Barnes-Jewish Hospital Resident
    Professional Medical Medicine - University of California, Los Angeles School of Medicine M.D.
    Chemistry with emphasis in Biochemistry - University of Utah B.S.

    Selected Publications

    Journal Article

    1. Kagawa H, Stringham J, Selzman C, Goodwin M, Frye L, Raman S, Cahill B, Morrell M (2023). Case Report of Needle Disruption of the Retroperitoneal Lymph Nodes for Refractory Chylothorax After Double Lung Transplantation. Transplant Proc, 55(8), 1981-1983. (Read full article)
    2. Fredrick SR, Iasella CJ, Sacha LM, Rivosecchi RM, Morrell MR, Sanchez PG, Pilewski JM, Snyder ME, McDyer JF, Moore CA (2023). Incidence of Acute Cellular Rejection After Granulocyte Colony-Stimulating Factor in Lung Transplant Recipients. J Pharm Pract, 8971900231184308. (Read full article)
    3. Vendetti ML, Esther Moon SJ, Imes CC, Hergenroeder A, Sciurba F, Lendermon E, Pilewski J, Ren D, Parmanto B, Dewhirst B, Willey B, Jones K, Morrell MR, Sanchez P, DeVito Dabbs A (2023). Design of Lung Transplant Go (LTGO): A randomized controlled trial evaluating the efficacy of a telerehabilitation behavioral exercise intervention to improve physical activity, physical function, and blood pressure control after lung transplantation. Contemp Clin Trials Commun, 33, 101097. (Read full article)
    4. Hyzny EJ, Chan EG, Malik SM, Morrell M, Furukawa M, Ryan JP, Sanchez PG (2022). Risk Factors and Outcomes of Postoperative Hepatic Dysfunction After Lung Transplantation. Ann Thorac Surg. (Read full article)
    5. Haidar G, Agha M, Bilderback A, Lukanski A, Linstrum K, Troyan R, Rothenberger S, McMahon DK, Crandall MD, Sobolewksi MD, Nathan Enick P, Jacobs JL, Collins K, Klamar-Blain C, Macatangay BJC, Parikh UM, Heaps A, Coughenour L, Schwartz MB, Dueker JM, Silveira FP, Keebler ME, Humar A, Luketich JD, Morrell MR, Pilewski JM, McDyer JF, Pappu B, Ferris RL, Marks SM, Mahon J, Mulvey K, Hariharan S, Updike GM, Brock L, Edwards R, Beigi RH, Kip PL, Wells A, Minnier T, Angus DC, Mellors JW (2021). Prospective Evaluation of Coronavirus Disease 2019 (COVID-19) Vaccine Responses Across a Broad Spectrum of Immunocompromising Conditions: the COVID-19 Vaccination in the Immunocompromised Study (COVICS). Clin Infect Dis, 75(1), e630-e644. (Read full article)
    6. Chan EG, Hyzny EJ, Furukawa M, Ryan JP, Subramaniam K, Morrell MR, Pilewski J, Luketich JD, Sanchez PG (2022). Intraoperative Support for Primary Bilateral Lung Transplantation: A Propensity Matched Analysis. Ann Thorac Surg. (Read full article)
    7. Chan EG, Hyzny EJ, Ryan JP, Morrell MR, Pilewski J, Sanchez PG (2021). Outcomes following lung re-transplantation in patients with cystic fibrosis. J Cyst Fibros, 21(3), 482-488. (Read full article)
    8. Furukawa M, Chan EG, Morrell MR, Ryan JP, Rivosecchi RM, Iasella CJ, Lendermon EA, Pilewski JM, Sanchez PG (2022). Risk factors of bronchial dehiscence after primary lung transplantation. J Card Surg, 37(4), 950-957. (Read full article)
    9. Harano T, Chan EG, Furukawa M, Reck Dos Santos P, Morrell MR, Sappington PL, Sanchez PG (2021). Oxygenated right ventricular assist device with a percutaneous dual-lumen cannula as a bridge to lung transplantation. J Thorac Dis, 14(4), 832-840. (Read full article)
    10. Haidar G, Agha M, Bilderback A, Lukanski A, Linstrum K, Troyan R, Rothenberger S, McMahon DK, Crandall MD, Sobolewksi MD, Enick PN, Jacobs JL, Collins K, Klamar-Blain C, Macatangay BJC, Parikh UM, Heaps A, Coughenour L, Schwartz MB, Dueker JM, Silveira FP, Keebler ME, Humar A, Luketich JD, Morrell MR, Pilewski JM, McDyer JF, Pappu B, Ferris RL, Marks SM, Mahon J, Mulvey K, Hariharan S, Updike GM, Brock L, Edwards R, Beigi RH, Kip PL, Wells A, Minnier T, Angus DC, Mellors JW (2022). Prospective evaluation of COVID-19 vaccine responses across a broad spectrum of immunocompromising conditions: the COVICS study. Clin Infect Dis, 4(6), 1115-1130. (Read full article)
    11. Moon SJE, Dabbs AD, Hergenroeder AL, Vendetti ML, Jones KB, Willey BM, Morrell MR, Imes CC (2021). Considerations for assessing physical function and physical activity in clinical trials during the COVID-19 pandemic. Contemp Clin Trials, 105, 106407. (Read full article)
    12. Christie IG, Chan EG, Ryan JP, Harano T, Morrell M, Luketich JD, Sanchez PG (2020). National Trends in Extended Criteria Donor Utilization and Outcomes for Lung Transplantation. Ann Thorac Surg, 111(2), 421-426. (Read full article)
    13. Harano T, Ryan JP, Chan EG, Noda K, Morrell MR, Luketich JD, Sanchez PG (2020). Lung transplantation for the treatment of irreversible acute respiratory distress syndrome. Clin Transplant, 35(2), e14182. (Read full article)
    14. Harano T, Ryan JP, Morrell MR, Luketich JD, Sanchez PG (2021). Extracorporeal Membrane Oxygenation for Primary Graft Dysfunction After Lung Transplantation. ASAIO J, 67, 1071-1078. (Read full article)
    15. Chan EG, Chan PG, Harano T, Ryan JP, Morrell MR, Sanchez PG (2020). Trends in Lung Transplantation Practices Across the United States During the COVID-19 Pandemic. Transplantation, 105(1), 187-192. (Read full article)
    16. Harano T, Rivosecchi RM, Morrell MR, Sanchez PG (2020). Dabigatran reversal with idarucizumab prior to lung transplantation. Clin Transplant, 35(1), e14142. (Read full article)
    17. Iasella CJ, Ensor CR, Marrari M, Mangiola M, Xu Q, Nolley E, Moore CA, Morrell MR, Pilewski JM, Sanchez PG, McDyer JF, Zeevi A (2020). Donor-specific antibody characteristics, including persistence and complement-binding capacity, increase risk for chronic lung allograft dysfunction. J Heart Lung Transplant, 39(12), 1417-1425. (Read full article)
    18. Iasella CJ, Hoji A, Popescu I, Wei J, Snyder ME, Zhang Y, Xu W, Iouchmanov V, Koshy R, Brown M, Fung M, Langelier C, Lendermon EA, Dugger D, Shah R, Lee J, Johnson B, Golden J, Leard LE, Ellen Kleinhenz M, Kilaru S, Hays SR, Singer JP, Sanchez PG, Morrell MR, Pilewski JM, Greenland JR, Chen K, McDyer JF (2020). Type-1 immunity and endogenous immune regulators predominate in the airway transcriptome during chronic lung allograft dysfunction. Am J Transplant, 21, 2145-2160. (Read full article)
    19. Chan EG, Morrell MR, Chan PG, Sanchez PG (2020). Bilateral sequential lung transplantation in Jehovah's Witnesses. Perfusion, 36, 267659120939364. (Read full article)
    20. Chan EG, Hayanga JWA, Tuft M, Morrell MR, Sanchez PG (2021). Access to Lung Transplantation in the United States: The Potential Impact of Access to a High-volume Center. Transplantation, 104(7), e199-e207. (Read full article)
    21. Samanta P, Clancy CJ, Marini RV, Rivosecchi RM, McCreary EK, Shields RK, Falcione BA, Viehman A, Sacha L, Kwak EJ, Silveira FP, Sanchez PG, Morrell M, Clarke L, Nguyen MH (2020). Isavuconazole is as effective as and better tolerated than voriconazole for antifungal prophylaxis in lung transplant recipients. Clin Infect Dis. (Read full article)
    22. Iasella CJ, Winters SA, Kois A, Cho J, Hannan SJ, Koshy R, Moore CA, Ensor CR, Lendermon EA, Morrell MR, Pilewski JM, Sanchez PG, Kass DJ, Alder JK, Nouraie SM, McDyer JF (2020). Idiopathic pulmonary fibrosis lung transplant recipients are at increased risk for EBV-associated posttransplant lymphoproliferative disorder and worse survival. Am J Transplant, 20(5), 1439-1446. (Read full article)
    23. Nolley E, Fleck J, Kavalieratos D, Dew MA, Dilling D, Colman R, Crespo MM, Goldberg H, Hays S, Hachem R, Lease E, Lee J, Reynolds J, Morrell M, Schenker Y (2020). Lung Transplant Pulmonologists' Views of Specialty Palliative Care for Lung Transplant Recipients. J Palliat Med, 23(5), 619-626. (Read full article)
    24. Harano T, DCunha J, Kilaru S, Morrell MR, Luketich JD, Sanchez PG (2019). Extracorporeal Membrane Oxygenation to Overcome Graft-Cavity Disparity of Lung Transplantation. Ann Thorac Surg, 109(4), e275-e277. (Read full article)
    25. Jorge A, Sanchez PG, Hayanga JWA, Pilewski JM, Morrell M, Tuft M, Ryan J, DCunha J (2019). Routine deep vein thrombosis screening after lung transplantation: Incidence and risk factors. J Thorac Cardiovasc Surg, 159(3), 1142-1150. (Read full article)
    26. Thanukrishnan H, Corcoran TE, Iasella CJ, Moore CA, Nero JA, Morrell MR, McDyer JF, Hussain S, Nguyen MH, Venkataramanan R, Ensor CR (2019). Aerosolization of Second-generation Triazoles: In Vitro Evaluation and Application in Therapy of Invasive Airway Aspergillosis. Transplantation, 103(12), 2608-2613. (Read full article)
    27. Morrell MR, Kiel SC, Pilewski JM (2019). Organ Transplantation for Cystic Fibrosis. Semin Respir Crit Care Med, 40(6), 842-856. (Read full article)
    28. Nolley EP, DeSensi R, Nouraie M, Schenker Y, Morrell MR (2019). Characteristics, Trends, and Predictors of Specialty Palliative Care Utilization after Lung Transplantation. J Palliat Med, 22(9), 1092-1098. (Read full article)
    29. Karnes HE, Schindler EI, Morrell M, Hachem RR, Berman K, Vedantham S, Atkinson J, Spitznagel E, Despotis GJ (2018). Factors Associated With Mortality and Response to Extracorporeal Photopheresis in Lung Allograft Recipients With Bronchiolitis Obliterans Syndrome. Transplantation, 103(5), 1036-1042. (Read full article)
    30. Popescu I, Mannem H, Winters SA, Hoji A, Silveira F, McNally E, Pipeling MR, Lendermon EA, Morrell MR, Pilewski JM, Hanumanthu VS, Zhang Y, Gulati S, Shah PD, Iasella CJ, Ensor CR, Armanios M, McDyer JF (2018). Impaired Cytomegalovirus Immunity in Idiopathic Pulmonary Fibrosis Lung Transplant Recipients with Short Telomeres. Am J Respir Crit Care Med, 199(3), 362-376. (Read full article)
    31. Hamad Y, Pilewski JM, Morrell M, DCunha J, Kwak EJ (2019). Outcomes in Lung Transplant Recipients With Mycobacterium abscessus Infection: A 15-Year Experience From a Large Tertiary Care Center. Transplant Proc, 51(6), 2035-2042. (Read full article)
    32. Lichvar AB, Ensor CR, Zeevi A, Morrell MR, Pilewski JM, Hayanga JWA, DCunha J, McDyer JF, Petrov AA (2018). Detrimental Association of Hypogammaglobulinemia With Chronic Lung Allograft Dysfunction and Death Is Not Mitigated by On-Demand Immunoglobulin G Replacement After Lung Transplantation. Prog Transplant, 1526924818817028. (Read full article)
    33. Ensor CR, Goehring KC, Iasella CJ, Moore CA, Lendermon EA, McDyer JF, Morrell MR, Sciortino CM, Venkataramanan R, Wiland AM (2018). Belatacept for maintenance immunosuppression in cardiothoracic transplantation: The potential frontier. Clin Transplant, 32(10), e13363. (Read full article)
    34. Kim F, Dezfulian C, Empey PE, Morrell M, Olsufka M, Scruggs S, Kudenchuk P, May S, Maynard C, Sayre MR, Nichol G (2018). Usefulness of Intravenous Sodium Nitrite During Resuscitation for the Treatment of Out-of-Hospital Cardiac Arrest. Am J Cardiol, 122(4), 554-559. (Read full article)
    35. Ensor CR, Iasella CJ, Harrigan KM, Morrell MR, Moore CA, Shigemura N, Zeevi A, McDyer JF, Venkataramanan R (2018). Increasing tacrolimus time-in-therapeutic range is associated with superior one-year outcomes in lung transplant recipients. Am J Transplant, 18(6), 1527-1533. (Read full article)
    36. Cheng J, Moore CA, Iasella CJ, Glanville AR, Morrell MR, Smith RB, McDyer JF, Ensor CR (2018). Systematic review and meta-analysis of post-transplant lymphoproliferative disorder in lung transplant recipients. Clin Transplant, 32(5), e13235. (Read full article)
    37. Naik C, Moore C, Pipeling M, DCunha J, Ruppert K, Ensor C, Morrell M (2018). Cyclophosphamide for Refractory Acute Cellular Rejection After Lung Transplantation. Transplant Direct, 4(5), e350. (Read full article)
    38. Hess NR, Esper SA, Awori Hayanga JW, Tuft M, Morrell M, DCunha J (2018). Patent foramen ovale repair at the time of double lung transplantation: Necessary or not? Clin Transplant, e13201. (Read full article)
    39. Iasella CJ, Winstead RJ, Moore CA, Johnson BA, Feinberg AT, Morrell MR, Hayanga JWA, Lendermon EA, Zeevi A, McDyer JF, Ensor CR (2017). Maintenance Belatacept-Based Immunosuppression in Lung Transplantation Recipients Who Failed Calcineurin Inhibitors. Transplantation, 102(1), 171-177. (Read full article)
    40. Hayanga AJ, Du AL, Joubert K, Tuft M, Baird R, Pilewski J, Morrell M, DCunha J, Shigemura N (2017). Mechanical Ventilation and Extracorporeal Membrane Oxygenation as a Bridging Strategy to Lung Transplantation: Significant Gains in Survival. Am J Transplant, 18(1), 125-135. (Read full article)
    41. Hayanga JWA, Shigemura N, Aboagye JK, Ensor C, Dew MA, Hayanga HK, Esper SA, Joubert K, Morrell MR, DCunha J (2017). ECMO Support in Lung Transplantation: A Contemporary Analysis of Hospital Charges in the United States. Ann Thorac Surg, 104(3), 1033-1039. (Read full article)
    42. Moore CA, Pilewski JM, Venkataramanan R, Robinson KM, Morrell MR, Wisniewski SR, Zeevi A, McDyer JF, Ensor CR (2017). Effect of aerosolized antipseudomonals on Pseudomonas positivity and bronchiolitis obliterans syndrome after lung transplantation. Transpl Infect Dis, 19(3). (Read full article)
    43. Ensor CR, Yousem SA, Marrari M, Morrell MR, Mangiola M, Pilewski JM, DCunha J, Wisniewski SR, Venkataramanan R, Zeevi A, McDyer JF (2017). Proteasome Inhibitor Carfilzomib-Based Therapy for Antibody-Mediated Rejection of the Pulmonary Allograft: Use and Short-Term Findings. Am J Transplant, 17(5), 1380-1388. (Read full article)
    44. Ensor CR, Rihtarchik LC, Morrell MR, Hayanga JW, Lichvar AB, Pilewski JM, Wisniewski S, Johnson BA, DCunha J, Zeevi A, McDyer JF (2017). Rescue alemtuzumab for refractory acute cellular rejection and bronchiolitis obliterans syndrome after lung transplantation. Clin Transplant, 31(4). (Read full article)
    45. Choi J, Hergenroeder AL, Burke L, Dabbs AD, Morrell M, Saptono A, Parmanto B (2016). Delivering an in-Home Exercise Program via Telerehabilitation: A Pilot Study of Lung Transplant Go (LTGO). Int J Telerehabil, 8(2), 15-26. (Read full article)
    46. Mahesh B, Bhama JK, Odell DD, Hayanga AJ, Bermudez CA, Morrell MR, Crespo MM, Pilewski JM, Johnson BA, Luketich JD, DCunha J, Shigemura N (2016). Surgical Strategy for Lung Transplantation in Adults With Small Chests: Lobar Transplant Versus a Pediatric Donor. Transplantation, 100(12), 2693-2698. (Read full article)
    47. DAngelo AM, Chan EG, Hayanga JW, Odell DD, Pilewski J, Crespo M, Morrell M, Shigemura N, Luketich J, Bermudez C, Althouse AD, DCunha J (2016). Atrial arrhythmias after lung transplantation: Incidence and risk factors in 652 lung transplant recipients. J Thorac Cardiovasc Surg, 152(3), 901-9. (Read full article)
    48. Crespo MM, Bermudez CA, Dew MA, Johnson BA, George MP, Bhama J, Morrell M, DCunha J, Shigemura N, Richards TJ, Pilewski JM (2015). Lung Transplant in Patients with Scleroderma Compared with Pulmonary Fibrosis. Short- and Long-Term Outcomes. Ann Am Thorac Soc, 13(6), 784-92. (Read full article)
    49. Chan EG, Bianco V 3rd, Richards T, Hayanga JW, Morrell M, Shigemura N, Crespo M, Pilewski J, Luketich J, DCunha J (2015). The ripple effect of a complication in lung transplantation: Evidence for increased long-term survival risk. J Thorac Cardiovasc Surg, 151(4), 1171-9. (Read full article)
    50. Morrell MR, Pilewski JM (2016). Lung Transplantation for Cystic Fibrosis. Clin Chest Med, 37(1), 127-38. (Read full article)
    51. Hayanga AJ, Aboagye JK, Hayanga HE, Morrell M, Huffman L, Shigemura N, Bhama JK, DCunha J, Bermudez CA (2014). Contemporary analysis of early outcomes after lung transplantation in the elderly using a national registry. J Heart Lung Transplant, 34(2), 182-8. (Read full article)
    52. Morrell MR, Pilewski JM, Gries CJ, Pipeling MR, Crespo MM, Ensor CR, Yousem SA, DCunha J, Shigemura N, Bermudez CA, McDyer JF, Zeevi A (2014). De novo donor-specific HLA antibodies are associated with early and high-grade bronchiolitis obliterans syndrome and death after lung transplantation. J Heart Lung Transplant, 33(12), 1288-94. (Read full article)
    53. Ortiz-Pujols S, Jones SW, Short KA, Morrell MR, Bermudez CA, Tilley SL, Cairns BA (2014). Management and sequelae of a 41-year-old jehovah's witness with severe anhydrous ammonia inhalation injury. J Burn Care Res, 35(3), e180-3. (Read full article)
    54. Hoppo T, Jarido V, Pennathur A, Morrell M, Crespo M, Shigemura N, Bermudez C, Hunter JG, Toyoda Y, Pilewski J, Luketich JD, Jobe BA (2011). Antireflux surgery preserves lung function in patients with gastroesophageal reflux disease and end-stage lung disease before and after lung transplantation. Arch Surg, 146(9), 1041-7. (Read full article)
    55. Jain R, Hachem RR, Morrell MR, Trulock EP, Chakinala MM, Yusen RD, Huang HJ, Mohanakumar T, Patterson GA, Walter MJ (2010). Azithromycin is associated with increased survival in lung transplant recipients with bronchiolitis obliterans syndrome. J Heart Lung Transplant, 29(5), 531-7. (Read full article)
    56. Morrell MR, Despotis GJ, Lublin DM, Patterson GA, Trulock EP, Hachem RR (2009). The efficacy of photopheresis for bronchiolitis obliterans syndrome after lung transplantation. J Heart Lung Transplant, 29(4), 424-31. (Read full article)
    57. Morrell MR, Micek ST, Kollef MH (2009). The management of severe sepsis and septic shock. Infect Dis Clin North Am, 23(3), 485-501. (Read full article)
    58. Lawrence KL, Morrell MR, Storch GA, Hachem RR, Trulock EP (2009). Clinical outcomes of solid organ transplant recipients with ehrlichiosis. Transpl Infect Dis, 11(3), 203-10. (Read full article)
    59. Morrell MR, Patterson GA, Trulock EP, Hachem RR (2008). Acute antibody-mediated rejection after lung transplantation. J Heart Lung Transplant, 28(1), 96-100. (Read full article)
    60. Morrell MR, Dallas J, Kollef MH (2008). A 50-year-old woman with abdominal pain and respiratory failure 3 months after kidney transplantation. Chest, 134(2), 442-446. (Read full article)
    61. Shorr AF, Lazarus DR, Sherner JH, Jackson WL, Morrell M, Fraser VJ, Kollef MH (2007). Do clinical features allow for accurate prediction of fungal pathogenesis in bloodstream infections? Potential implications of the increasing prevalence of non-albicans candidemia. Crit Care Med, 35(4), 1077-83. (Read full article)
    62. Wu CW, Morrell MR, Heinze E, Concoff AL, Wollaston SJ, Arnold EL, Singh R, Charles C, Skovrun ML, FitzGerald JD, Moreland LW, Kalunian KC (2005). Validation of American College of Rheumatology classification criteria for knee osteoarthritis using arthroscopically defined cartilage damage scores. Semin Arthritis Rheum, 35(3), 197-201. (Read full article)
    63. Morrell M, Fraser VJ, Kollef MH (2005). Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob Agents Chemother, 49(9), 3640-5. (Read full article)

    Case Report

    1. Chan PG, Sanchez PG, Morrell MR, Kilic A, Sultan I (2019). Concomitant surgical aortic valve replacement with bilateral orthotopic lung transplantation. J Card Surg, 35(2), 470-472. (Read full article)
    2. Harano T, Haidar G, Schaheen L, Morrell MR, Pilewski JM, DCunha J (2019). Successful lung transplantation from a hepatitis C RNA-positive donor to a hepatitis C treatment-experienced recipient with cystic fibrosis. J Thorac Cardiovasc Surg, 158(4), e155-e157. (Read full article)
    3. George MP, Novelli EM, Shigemura N, Simon MA, Feingold B, Krishnamurti L, Morrell MR, Gries CG, Haider S, Johnson BA, Crespo MM, Bhama JK, Bermudez C, Yousem SA, Toyoda Y, Champion HC, Pilewski JM, Gladwin MT (2013). First successful lung transplantation for sickle cell disease with severe pulmonary arterial hypertension and pulmonary veno-occlusive disease. Pulm Circ, 3(4), 952-8. (Read full article)

    Editorial

    1. Chan EG, Harano T, Morrell MR, Sanchez PG (2021). Lung transplantation protocols during the COVID-19 pandemic: a single center experience. J Thorac Dis, 13(4), 2081-2086. (Read full article)
    2. Martinu T, Koutsokera A, Benden C, Cantu E, Chambers D, Cypel M, Edelman J, Emtiazjoo A, Fisher AJ, Greenland JR, Hayes D Jr, Hwang D, Keller BC, Lease ED, Perch M, Sato M, Todd JL, Verleden S, von der Thsen J, Weigt SS, Keshavjee S, bronchoalveolar lavage standardization workgroup (2020). International Society for Heart and Lung Transplantation consensus statement for the standardization of bronchoalveolar lavage in lung transplantation. J Heart Lung Transplant, 39(11), 1171-1190. (Read full article)